| Q40454379 | BFRF1 of Epstein-Barr virus is essential for efficient primary viral envelopment and egress. |
| Q40454370 | Characterization and intracellular localization of the Epstein-Barr virus protein BFLF2: interactions with BFRF1 and with the nuclear lamina. |
| Q40011084 | Deletion of Epstein-Barr virus BFLF2 leads to impaired viral DNA packaging and primary egress as well as to the production of defective viral particles |
| Q38380369 | Epstein-Barr virus infection induces aberrant TLR activation pathway and fibroblast-myofibroblast conversion in scleroderma |
| Q38964209 | Epstein-barr virus blocks the autophagic flux and appropriates the autophagic machinery to enhance viral replication |
| Q42325519 | HHV-8 reduces dendritic cell migration through down-regulation of cell-surface CCR6 and CCR7 and cytoskeleton reorganization |
| Q40008314 | Identification and characterization of the product encoded by ORF69 of Kaposi's sarcoma-associated herpesvirus |
| Q40613857 | Intracellular localization of the Epstein-Barr virus BFRF1 gene product in lymphoid cell lines and oral hairy leukoplakia lesions |
| Q39159499 | KSHV ORF67 encoded lytic protein localizes on the nuclear membrane and alters emerin distribution |
| Q37418380 | Kaposi sarcoma associated herpesvirus (KSHV) induces AKT hyperphosphorylation, bortezomib-resistance and GLUT-1 plasma membrane exposure in THP-1 monocytic cell line |
| Q41366330 | PKC theta and p38 MAPK activate the EBV lytic cycle through autophagy induction |
| Q40331535 | Regulation of the expression of the Epstein-Barr virus early gene BFRF1. |
| Q28081199 | Targeting of prosurvival pathways as therapeutic approaches against primary effusion lymphomas: past, present, and Future |
| Q39590218 | The BFRF1 gene of Epstein-Barr virus encodes a novel protein |
| Q30817391 | The Ubiquitin Ligase Itch and Ubiquitination Regulate BFRF1-Mediated Nuclear Envelope Modification for Epstein-Barr Virus Maturation. |
| Q36777265 | The activation of KSHV lytic cycle blocks autophagy in PEL cells |